Arterial Thrombosis - Pipeline Review, H1 2017

Publisher Name :
Date: 31-Mar-2017
No. of pages: 45
Inquire Before Buying

Arterial Thrombosis - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis - Pipeline Review, H1 2017, provides an overview of the Arterial Thrombosis (Cardiovascular) pipeline landscape.

Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin and coldness. Depending on where the clot forms, arterial thrombosis can cause several serious conditions, including stroke, heart attack and peripheral arterial disease (PAD). Predisposing factors include smoking, obesity, diabetes, hypertension and high cholesterol level. Treatment includes thrombolytic agents and surgery.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Arterial Thrombosis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Arterial Thrombosis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 3, 7 and 1 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 4 molecules, respectively.

Arterial Thrombosis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Arterial Thrombosis (Cardiovascular).

- The pipeline guide reviews pipeline therapeutics for Arterial Thrombosis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Arterial Thrombosis (Cardiovascular) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Arterial Thrombosis (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Arterial Thrombosis (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Arterial Thrombosis (Cardiovascular).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Arterial Thrombosis (Cardiovascular) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Arterial Thrombosis - Pipeline Review, H1 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Arterial Thrombosis - Overview
Arterial Thrombosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Arterial Thrombosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Arterial Thrombosis - Companies Involved in Therapeutics Development
Astellas Pharma Inc
Bayer AG
Bristol-Myers Squibb Company
Eisai Co Ltd
Johnson & Johnson
Sanofi
Thromboserin Ltd
Arterial Thrombosis - Drug Profiles
AB-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AS-1468240 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ASP-6537 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BAY-1213790 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BMS-654457 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BMS-884775 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BMS-986120 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
C-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
E-5539 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ER-410660 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
JNJ-375 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptide to Inhibit PAI-1 for Arterial Thrombosis and Pulmonary Thromboembolism - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PZ-128 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Protein to Antagonize ITGA2B and ITGB3 for Arterial Thrombosis and Ischemic Cerebral Stroke - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SAR-216471 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit Integrin alpha 2 beta 1 for Arterial Thrombosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
THL-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Arterial Thrombosis - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Arterial Thrombosis, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Arterial Thrombosis - Pipeline by Astellas Pharma Inc, H1 2017
Arterial Thrombosis - Pipeline by Bayer AG, H1 2017
Arterial Thrombosis - Pipeline by Bristol-Myers Squibb Company, H1 2017
Arterial Thrombosis - Pipeline by Eisai Co Ltd, H1 2017
Arterial Thrombosis - Pipeline by Johnson & Johnson, H1 2017
Arterial Thrombosis - Pipeline by Sanofi, H1 2017
Arterial Thrombosis - Pipeline by Thromboserin Ltd, H1 2017
Arterial Thrombosis - Dormant Projects, H1 2017

List of Figures
Number of Products under Development for Arterial Thrombosis, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017
  • Global and Chinese Acquired Orphan Blood Diseases Therapeutics Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 135
    The 'Global and Chinese Acquired Orphan Blood Diseases Therapeutics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Acquired Orphan Blood Diseases Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Acquired Orphan Blood Diseases Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industr......
  • Global and Chinese Fibrinogen Concentrates Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 138
    The 'Global and Chinese Fibrinogen Concentrates Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Fibrinogen Concentrates industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fibrinogen Concentrates manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • Global and Chinese Low Molecular Weight Heparin Industry, 2018 Market Research Report
    Published: 12-Dec-2018        Price: US 3000 Onwards        Pages: 136
    The 'Global and Chinese Low Molecular Weight Heparin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Low Molecular Weight Heparin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Low Molecular Weight Heparin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overv......
  • Global and Chinese Heparin Sodium Industry, 2018 Market Research Report
    Published: 12-Dec-2018        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Heparin Sodium Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Heparin Sodium industry with a focus on the Chinese market. The report provides key statistics on the market status of the Heparin Sodium manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definiti......
  • Global and Chinese Anticoagulants Industry, 2018 Market Research Report
    Published: 11-Dec-2018        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Anticoagulants Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Anticoagulants industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anticoagulants manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definiti......
  • Global and Chinese Injectable Anticoagulants Industry, 2018 Market Research Report
    Published: 11-Dec-2018        Price: US 3000 Onwards        Pages: 150
    The 'Global and Chinese Injectable Anticoagulants Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Injectable Anticoagulants industry with a focus on the Chinese market. The report provides key statistics on the market status of the Injectable Anticoagulants manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of th......
  • Global and Chinese Deep Vein Thrombosis (DVT) Drug Industry, 2018 Market Research Report
    Published: 10-Dec-2018        Price: US 3000 Onwards        Pages: 147
    The 'Global and Chinese Deep Vein Thrombosis (DVT) Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Deep Vein Thrombosis (DVT) Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Deep Vein Thrombosis (DVT) Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a ba......
  • Global Hemophilia A Drug Market Insights, Forecast to 2025
    Published: 04-Dec-2018        Price: US 3900 Onwards        Pages: 126
    In 2017, the global Hemophilia A Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Hemophilia A Drug market based on company, product type, application and key regions. This report studies the global market size of Hemophilia A Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on......
  • Global and Chinese Antithrombotic Drugs Industry, 2018 Market Research Report
    Published: 28-Nov-2018        Price: US 3000 Onwards        Pages: 147
    The 'Global and Chinese Antithrombotic Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Antithrombotic Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antithrombotic Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry incl......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs